Keep up with the latest trends and applications of AI in healthcare from the experts at AllazoHealth. Find best practices, tools, and breakthroughs in using artificial intelligence to drive meaningful engagement and outcomes for patient support programs and pharmaceutical marketing.
In 2021, 48 million Medicare beneficiaries enrolled in Part D plans. Medication therapy management (MTM) for Medicare Part D endeavors to prevent dangerous drug mixes, overmedication, and drug misuse among people with certain qualifying chronic…
Read more
How recognizing the unique characteristics of each patient optimizes resources and maximizes impact Medication non-adherence is an age-old problem that pharmaceutical companies have been grappling with for decades. According to industry research, the global pharmaceutical industry loses…
Read more
AllazoHealth CEO Clifford Jones and Chief Operating Officer William Grambley recently answered questions about patient intervention data: what it is, how clients employ it, and how AllazoHealth uses this data to accurately predict individual patient…
Read more
Small study demonstrates smart pill bottles can improve adherence interventions for cancer patients A smart pill bottle platform improved adherence and patient satisfaction among a small sample of multiple myeloma patients, according to a paper…
Read more
Polypharmacy, the simultaneous use of multiple drugs, is becoming more common as the population ages. More than 30% of older adults in the United States take five or more drugs, typically for multiple chronic conditions.…
Read more
When patients have multiple prescriptions, especially for long-term conditions, refill dates often are not aligned and create barriers to adherence. So, pharmacies have been integrating medication synchronization programs into their workflow. Medication synchronization enables patients…
Read more
We live in exciting times for adherence, and the pharma industry is playing a critical role, according to Mark Degatano, a pharmaceutical industry analytics expert who is on the advisory board of AllazoHealth. Degatano’s expertise…
Read more
Payers, pharmacies and pharmaceutical companies are starting to join providers in recognizing that social determinants of health (SDOH) have a major impact on patient adherence and clinical outcomes. Healthcare organizations now face the challenge of…
Read more
Starting next year payers may have new opportunities to collect real world data that was previously fragmented, incomplete and in some cases unavailable. According to the rules going into effect January 1, 2021 by the…
Read more